• HOME
  • ABOUT US
    • About Us
    • About the Kos Foundation
    • Our Promise
    • Our Impact
    • Our Team
    • Who is Zdenko Kos, The Founder
    • Financial Report
  • RESEARCH
    • Research
    • 8 Cancers that can cause Cancer
    • Brain Tumour
    • Breast Cancer
    • Colon/Rectum Cancer
    • Lung/Bronchus Cancer
    • Prostate Cancer
    • Skin Cancer
  • WHAT WE FUND
    • What we fund
      • Procedure for Applying
      • Decision Making Process
      • What to Include
      • Distribution of funds
    • Scholarships, grants and bursaries
      • Scholarships, grants and bursaries: Scholarship Award £120,000 per annum
      • Scholarships, grants and bursaries: Academic Achievement Award UK & EU
      • Scholarships, grants and bursaries: 2024 Equity Scholarships
    • TAKE ACTION
  • PROJECTS
    • PROJECTS EXPOSED
    • Hospital Ulm Germany
    • Hospital Ljubljana (Domžale)
  • CONTACT US
    • Contact Us
    • TOP STORIES
  • TOP STORIES & REST
    • TOP STORIES I
    • OPEN LETTER TO UK GOVERNMENT
    • THE WINNERS AND THE LOSERS
    • DAN NEIDLE & TAX POLICY ASSOCIATES DELUSIONS
    • OPEN LETTER TO DAN NEIDLE & TAX POLICY ASSOCIATES DELUSIONS
    • MEDICAL EQUIPMENT for SALE
      • AOLIKE Beds
      • ECG Mobile Kardia
      • Tecan Fluent 780 Liquid Handler
      • Equipment and Offers 00
      • Equipment and Offers 02
      • Equipment and Offers 01
  • AVAILABLE TREATMENTS
    • AVAILABLE TREATMENTS
    • BRAIN CANCER (MARAGEANDON)
      • Brain cancer standard treatment
    • BREAST CANCER (GARDNAMERAB)
      • Breast cancer standard method treatment
    • COLON-RECTUM CANCER (ZAGEARDENAX)
      • Colorectum cancer standard method treatment
    • LUNG-BRONCHUS CANCER (GRAZUREADIN)
      • Lung cancer standard method treatment
    • PROSTATE CANCER (DAREXANATAN)
      • Prostate cancer standard treatment
    • SKIN CANCER (CUTISAXADAX)
    • STAGE 4 CANCER
      • STAGE 4 Laryngeal cancer
    • Your Questions Answered
  • HOME
  • ABOUT US
    • About Us
    • About the Kos Foundation
    • Our Promise
    • Our Impact
    • Our Team
    • Who is Zdenko Kos, The Founder
    • Financial Report
  • RESEARCH
    • Research
    • 8 Cancers that can cause Cancer
    • Brain Tumour
    • Breast Cancer
    • Colon/Rectum Cancer
    • Lung/Bronchus Cancer
    • Prostate Cancer
    • Skin Cancer
  • WHAT WE FUND
    • What we fund
      • Procedure for Applying
      • Decision Making Process
      • What to Include
      • Distribution of funds
    • Scholarships, grants and bursaries
      • Scholarships, grants and bursaries: Scholarship Award £120,000 per annum
      • Scholarships, grants and bursaries: Academic Achievement Award UK & EU
      • Scholarships, grants and bursaries: 2024 Equity Scholarships
    • TAKE ACTION
  • PROJECTS
    • PROJECTS EXPOSED
    • Hospital Ulm Germany
    • Hospital Ljubljana (Domžale)
  • CONTACT US
    • Contact Us
    • TOP STORIES
  • TOP STORIES & REST
    • TOP STORIES I
    • OPEN LETTER TO UK GOVERNMENT
    • THE WINNERS AND THE LOSERS
    • DAN NEIDLE & TAX POLICY ASSOCIATES DELUSIONS
    • OPEN LETTER TO DAN NEIDLE & TAX POLICY ASSOCIATES DELUSIONS
    • MEDICAL EQUIPMENT for SALE
      • AOLIKE Beds
      • ECG Mobile Kardia
      • Tecan Fluent 780 Liquid Handler
      • Equipment and Offers 00
      • Equipment and Offers 02
      • Equipment and Offers 01
  • AVAILABLE TREATMENTS
    • AVAILABLE TREATMENTS
    • BRAIN CANCER (MARAGEANDON)
      • Brain cancer standard treatment
    • BREAST CANCER (GARDNAMERAB)
      • Breast cancer standard method treatment
    • COLON-RECTUM CANCER (ZAGEARDENAX)
      • Colorectum cancer standard method treatment
    • LUNG-BRONCHUS CANCER (GRAZUREADIN)
      • Lung cancer standard method treatment
    • PROSTATE CANCER (DAREXANATAN)
      • Prostate cancer standard treatment
    • SKIN CANCER (CUTISAXADAX)
    • STAGE 4 CANCER
      • STAGE 4 Laryngeal cancer
    • Your Questions Answered
DONATE
© 2025 

All Rights Reserved | The ZDENKO KOS Foundation
Share by: